These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 1368594)

  • 1. Syntheses and biological activities of photolabile indolactam derivatives; new probes for the receptor analysis of tumor promoters.
    Okuno S; Irie K; Nishino H; Iwashima A; Koshimizu K
    Agric Biol Chem; 1990 Jul; 54(7):1885-7. PubMed ID: 1368594
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and biological activities of (-)-6-n-octyl-indolactam-V, a new potent analogue of the tumor promoter (-)-indolactam-V.
    Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H
    Biosci Biotechnol Biochem; 1998 Aug; 62(8):1568-73. PubMed ID: 9757563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of alteration of the heterocyclic nucleus of ILV on its isoform selectivity for PKC. Palladium catalyzed route to benzofuran analogues of ILV.
    Kozikowski AP; Ma D; Du L; Lewin NE; Bumberg PM
    Farmaco; 1995 Jun; 50(6):425-30. PubMed ID: 7669180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activities of indolactone-V, the lactone analogue of the tumor promoter (-)-indolactam-V.
    Nakagawa Y; Irie K; Nakamura Y; Ohigashi H; Hayashi H
    Biosci Biotechnol Biochem; 1997 Aug; 61(8):1415-7. PubMed ID: 9301127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular Total Synthesis of Protein Kinase C Activator (-)-Indolactam V.
    Haynes-Smith J; Diaz I; Billingsley KL
    Org Lett; 2016 May; 18(9):2008-11. PubMed ID: 27074538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative structure-activity studies on indole alkaloid tumor promoter indolactam congeners.
    Irie K; Okuno S; Kajiyama S; Koshimizu K; Nishino H; Iwashima A
    Carcinogenesis; 1991 Oct; 12(10):1883-6. PubMed ID: 1934269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity studies on synthetic analogues (indolactams) of the tumor promoter teleocidin.
    Fujiki H; Suganuma M; Nakayasu M; Tahira T; Endo Y; Shudo K; Sugimura T
    Gan; 1984 Oct; 75(10):866-70. PubMed ID: 6595181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New fluorescent 2-phenylindolglyoxylamide derivatives as probes targeting the peripheral-type benzodiazepine receptor: design, synthesis, and biological evaluation.
    Taliani S; Simorini F; Sergianni V; La Motta C; Da Settimo F; Cosimelli B; Abignente E; Greco G; Novellino E; Rossi L; Gremigni V; Spinetti F; Chelli B; Martini C
    J Med Chem; 2007 Jan; 50(2):404-7. PubMed ID: 17228885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic analogues (indolactams) of (-)-indolactam-V are new congeners of the teleocidin class of tumor promoters.
    Hirota M; Suganuma M; Yoshizawa S; Horiuchi T; Nakayasu M; Hasegawa M; Endo Y; Shudo K; Fujiki H
    Jpn J Cancer Res; 1987 Jun; 78(6):577-82. PubMed ID: 3112073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amide hydrogen of (-)-indolactam-V and benzolactam-V8's plays a critical role in protein kinase C binding and tumor-promoting activities.
    Nakagawa Y; Irie K; Nakamura Y; Ohigashi H
    Bioorg Med Chem Lett; 2001 Mar; 11(5):723-8. PubMed ID: 11266178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total synthesis of (-)-indolactam V.
    Xu Z; Zhang F; Zhang L; Jia Y
    Org Biomol Chem; 2011 Apr; 9(7):2512-7. PubMed ID: 21340068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
    Sugimoto T; Itagaki K; Irie K
    Bioorg Med Chem; 2008 Jan; 16(2):650-7. PubMed ID: 17977729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overturning indolyne regioselectivities and synthesis of indolactam V.
    Bronner SM; Goetz AE; Garg NK
    J Am Chem Soc; 2011 Mar; 133(11):3832-5. PubMed ID: 21351773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis and stereochemistry of cytoblastin.
    Moreno OA; Kishi Y
    Bioorg Med Chem; 1998 Aug; 6(8):1243-54. PubMed ID: 9784866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of protein kinase C activity and [3H]phorbol 12,13-dibutyrate binding by various tumor promoters in mouse brain cytosol.
    Leach KL; Blumberg PM
    Cancer Res; 1985 May; 45(5):1958-63. PubMed ID: 3157441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of phorbol diester promoters in epidermal cells in culture.
    Berry DL; Slaga TJ; Fürstenberger G; Marks F
    Carcinog Compr Surv; 1982; 7():237-42. PubMed ID: 7066920
    [No Abstract]   [Full Text] [Related]  

  • 17. Specific binding of phorbol ester tumor promoters to mouse tissues and cultured cells.
    Blumberg PM; Delclos KB; Dunphy WG; Jaken S
    Carcinog Compr Surv; 1982; 7():519-35. PubMed ID: 7039833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and live cell imaging of novel fluorescent duocarmycin analogs.
    Tietze LF; Behrendt F; Pestel GF; Schuberth I; Mitkovski M
    Chem Biodivers; 2012 Nov; 9(11):2559-70. PubMed ID: 23161634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modification of the naphthoyl 3-position of JWH-015: in search of a fluorescent probe to the cannabinoid CB2 receptor.
    Yates AS; Doughty SW; Kendall DA; Kellam B
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3758-62. PubMed ID: 15993070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophanol-derived oxazolopiperidone lactams: identification of a hit compound as NMDA receptor antagonist.
    Pereira NA; Sureda FX; Esplugas R; Pérez M; Amat M; Santos MM
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3333-6. PubMed ID: 24974339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.